QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer
NCT07342283
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Triple Negative Breast Cancer (TNBC)
Interventions
DRUG:
Immunotherapy combined with chemotherapy
Sponsor
Affiliated Hospital of Nantong University